The Hair Loss Encyclopedia

Search

for
Search:

GlossaryDupilumab (Dupixent)

monoclonal antibody treating inflammatory conditions like eczema and asthma

Dupilumab is a monoclonal antibody medication used to treat certain inflammatory conditions like eczema (atopic dermatitis) and asthma. It works by blocking specific proteins (IL-4 and IL-13) involved in the body's immune response, thereby reducing inflammation and symptoms.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 32 results

research Dupilumab in Inflammatory Skin Diseases: A Systematic Review

72 citations , March 2023 in “Biomolecules”

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Drug-Induced Alopecia After Dupilumab Therapy

research Drug-Induced Alopecia After Dupilumab Therapy

49 citations , December 2018 in “JAAD case reports”

Dupilumab may cause significant hair loss, which can reverse after stopping the drug.

research Dupilumab Improved Alopecia Areata in a Patient with Atopic Dermatitis: A Case Report

33 citations , January 2019 in “Acta Dermato Venereologica”

Dupilumab may help regrow hair in people with atopic dermatitis.

research Learning From Success and Failure: Biologics for Non-Approved Skin Diseases

20 citations , August 2019 in “Frontiers in immunology”

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

research Dupilumab Therapy for Alopecia Areata in Pediatric Patients with Concomitant Atopic Dermatitis

19 citations , January 2021 in “Journal of the American Academy of Dermatology”

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

View more "dupixent" in research →

Community Join

0 / 0 results

— no results